Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression

被引:61
作者
Patten, CA [1 ]
Martin, JE [1 ]
Myers, MG [1 ]
Calfas, KJ [1 ]
Williams, CD [1 ]
机构
[1] San Diego State Univ & Univ Calif San Diego, Sch Med Joint Doctoral Program Clin Psychol, San Diego, CA 92122 USA
来源
JOURNAL OF STUDIES ON ALCOHOL | 1998年 / 59卷 / 03期
关键词
D O I
10.15288/jsa.1998.59.327
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Alcohol dependence and major depression have been associated with heavy cigarette use and poor smoking-treatment outcomes. This preliminary study examined the efficacy of a mood management intervention for smoking cessation in abstinent alcoholics with a history of major depression. Method: Participants were 29 (15 female, 14 male) heavy smokers (mean cigs/day = 30.2), with an average of 6.8 years of continuous abstinence from alcohol and drugs, randomized to behavioral counseling (BC) (n = 16) or behavioral counseling + cognitive-behavioral mood management (CBT) (n = 13). A 2 x 5 repeated measures design was used to evaluate the effectiveness of the interventions on smoking outcome at baseline, posttreatment and at 1-, 3- and 12-month-follow-up. Self-reported smoking status was verified with biochemical (COa) and informant report. Results: Verified self-report indicated that significantly more smokers in CBT quit by posttreatment (69.2%; 9 of 13) than in BC (31.3%; 5 of 16) (chi(2) = 4.14, 1 df, p = .04). These abstinence rates remained unchanged at 1-month follow-up. At 3-month follow-up, differences in smoking abstinence rates were nonsignificant between CBT (46.2%; 6 of 13) and BC (25.0%; 4 of 16) conditions. However, at 12-month follow-up, significantly more participants in CBT were abstinent from smoking (46.2%; 6 of 13) than in BC (12.5%; 2 of 16) (chi(2) = 4.07, 1 df, p = .04). Conclusions: The results suggest that interventions focused on managing negative mood may benefit these high-risk, comorbid smokers.
引用
收藏
页码:327 / 335
页数:9
相关论文
共 33 条
[1]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[2]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[3]  
BECK AT, 1979, COGNITIVE THERAPY DE
[4]  
Beck ATSRA., 1987, Manual for the Beck Depression Inventory
[5]   A REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR (MOCLOBEMIDE) FACILITATES SMOKING CESSATION AND ABSTINENCE IN HEAVY, DEPENDENT SMOKERS [J].
BERLIN, I ;
SAID, S ;
SPREUXVAROQUAUX, O ;
LAUNAY, JM ;
OLIVARES, R ;
MILLET, V ;
LECRUBIER, Y ;
PUECH, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (04) :444-452
[6]  
BLOT WJ, 1988, CANCER RES, V48, P3282
[7]   NICOTINE DEPENDENCE AND ALCOHOLISM EPIDEMIOLOGY AND TREATMENT [J].
BOBO, JK .
JOURNAL OF PSYCHOACTIVE DRUGS, 1989, 21 (03) :323-329
[8]  
BRESLAU N, 1993, ARCH GEN PSYCHIAT, V50, P31
[9]  
BRESLAU N, 1992, AM J PSYCHIAT, V149, P464
[10]  
CLEARY R, 1967, DRUG EXP CLIN RES, V1, P115